| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein tyrosine kinase collagen receptor activity | 1.92e-05 | 2 | 88 | 2 | GO:0038062 | |
| GeneOntologyBiologicalProcess | regulation of ossification | 3.48e-05 | 147 | 86 | 6 | GO:0030278 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 7.58e-05 | 20 | 86 | 3 | GO:0006607 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane organization | 8.77e-05 | 56 | 86 | 4 | GO:0001941 | |
| GeneOntologyBiologicalProcess | neurotransmitter-gated ion channel clustering | 1.02e-04 | 22 | 86 | 3 | GO:0072578 | |
| GeneOntologyBiologicalProcess | sarcomere organization | 1.08e-04 | 59 | 86 | 4 | GO:0045214 | |
| GeneOntologyBiologicalProcess | seminiferous tubule development | 1.17e-04 | 23 | 86 | 3 | GO:0072520 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | ACSL6 DDR1 PTPN11 KIDINS220 LMAN1 ATRX UBAP2L DDR2 FER SNX27 LRP5 ROBO2 MAPK3 DCC ZNF804A PICALM | 1.47e-04 | 1366 | 86 | 16 | GO:0051130 |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid receptor clustering | 1.70e-04 | 5 | 86 | 2 | GO:0097112 | |
| GeneOntologyBiologicalProcess | extracellular matrix-cell signaling | 1.70e-04 | 5 | 86 | 2 | GO:0035426 | |
| GeneOntologyCellularComponent | RAVE complex | 4.89e-05 | 3 | 85 | 2 | GO:0043291 | |
| GeneOntologyCellularComponent | M band | 2.69e-04 | 31 | 85 | 3 | GO:0031430 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 4.50e-04 | 8 | 85 | 2 | GO:1990723 | |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 3 complex, eIF3m | 5.77e-04 | 9 | 85 | 2 | GO:0071541 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 7.20e-04 | 10 | 85 | 2 | GO:0044614 | |
| Domain | Rav1p_C | 2.10e-05 | 2 | 86 | 2 | IPR022033 | |
| Domain | DDR1/DDR2 | 2.10e-05 | 2 | 86 | 2 | IPR029553 | |
| Domain | Rav1p_C | 2.10e-05 | 2 | 86 | 2 | PF12234 | |
| Domain | EIF3C_N_dom | 2.10e-05 | 2 | 86 | 2 | IPR008905 | |
| Domain | eIF-3c_N | 2.10e-05 | 2 | 86 | 2 | PF05470 | |
| Domain | EIF3C | 2.10e-05 | 2 | 86 | 2 | IPR027516 | |
| Domain | - | 6.99e-05 | 48 | 86 | 4 | 2.120.10.80 | |
| Domain | Kelch-typ_b-propeller | 1.19e-04 | 55 | 86 | 4 | IPR015915 | |
| Domain | PolyA | 2.08e-04 | 5 | 86 | 2 | SM00517 | |
| Domain | - | 2.08e-04 | 5 | 86 | 2 | 1.10.1900.10 | |
| Domain | PABP | 2.08e-04 | 5 | 86 | 2 | PF00658 | |
| Domain | PABC | 2.08e-04 | 5 | 86 | 2 | PS51309 | |
| Domain | PABP_1234 | 2.08e-04 | 5 | 86 | 2 | IPR006515 | |
| Domain | PABP_HYD | 2.08e-04 | 5 | 86 | 2 | IPR002004 | |
| Domain | Ig_I-set | 2.45e-04 | 190 | 86 | 6 | IPR013098 | |
| Domain | I-set | 2.45e-04 | 190 | 86 | 6 | PF07679 | |
| Domain | Kelch_1 | 3.05e-04 | 70 | 86 | 4 | PF01344 | |
| Domain | Kelch_1 | 3.05e-04 | 70 | 86 | 4 | IPR006652 | |
| Domain | GCC2_Rab_bind | 4.34e-04 | 7 | 86 | 2 | IPR032023 | |
| Domain | Rab_bind | 4.34e-04 | 7 | 86 | 2 | PF16704 | |
| Domain | DHC_N1 | 5.76e-04 | 8 | 86 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 5.76e-04 | 8 | 86 | 2 | IPR013594 | |
| Domain | IGc2 | 7.56e-04 | 235 | 86 | 6 | SM00408 | |
| Domain | Ig_sub2 | 7.56e-04 | 235 | 86 | 6 | IPR003598 | |
| Domain | fn3 | 9.13e-04 | 162 | 86 | 5 | PF00041 | |
| Domain | - | 9.21e-04 | 10 | 86 | 2 | 1.10.220.60 | |
| Domain | Grip | 1.12e-03 | 11 | 86 | 2 | SM00755 | |
| Domain | GRIP | 1.12e-03 | 11 | 86 | 2 | PF01465 | |
| Domain | Tyr_kinase_rcpt_2_CS | 1.12e-03 | 11 | 86 | 2 | IPR002011 | |
| Domain | Ran_BP1 | 1.34e-03 | 12 | 86 | 2 | PF00638 | |
| Domain | GRIP_dom | 1.34e-03 | 12 | 86 | 2 | IPR000237 | |
| Domain | RECEPTOR_TYR_KIN_II | 1.34e-03 | 12 | 86 | 2 | PS00239 | |
| Domain | GRIP | 1.34e-03 | 12 | 86 | 2 | PS50913 | |
| Domain | RANBD1 | 1.34e-03 | 12 | 86 | 2 | PS50196 | |
| Domain | RanBD | 1.58e-03 | 13 | 86 | 2 | SM00160 | |
| Domain | Ran_bind_dom | 1.58e-03 | 13 | 86 | 2 | IPR000156 | |
| Domain | FN3 | 1.65e-03 | 185 | 86 | 5 | SM00060 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.84e-03 | 14 | 86 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.84e-03 | 14 | 86 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.84e-03 | 14 | 86 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.84e-03 | 14 | 86 | 2 | PF08393 | |
| Domain | MT | 1.84e-03 | 14 | 86 | 2 | PF12777 | |
| Domain | AAA_8 | 1.84e-03 | 14 | 86 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 1.84e-03 | 14 | 86 | 2 | IPR011704 | |
| Domain | AAA_5 | 1.84e-03 | 14 | 86 | 2 | PF07728 | |
| Domain | DHC_fam | 2.12e-03 | 15 | 86 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 2.12e-03 | 15 | 86 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 2.12e-03 | 15 | 86 | 2 | PF03028 | |
| Domain | FN3 | 2.26e-03 | 199 | 86 | 5 | PS50853 | |
| Domain | PINT | 2.41e-03 | 16 | 86 | 2 | SM00088 | |
| Domain | Kelch | 2.42e-03 | 58 | 86 | 3 | SM00612 | |
| Domain | PCI_dom | 2.72e-03 | 17 | 86 | 2 | IPR000717 | |
| Domain | PCI | 2.72e-03 | 17 | 86 | 2 | PF01399 | |
| Domain | FN3_dom | 2.80e-03 | 209 | 86 | 5 | IPR003961 | |
| Domain | BACK | 2.80e-03 | 61 | 86 | 3 | PF07707 | |
| Domain | BACK | 2.80e-03 | 61 | 86 | 3 | IPR011705 | |
| Domain | TPR_repeat | 3.33e-03 | 133 | 86 | 4 | IPR019734 | |
| Domain | FA58C | 4.16e-03 | 21 | 86 | 2 | SM00231 | |
| Domain | FA58C_3 | 4.16e-03 | 21 | 86 | 2 | PS50022 | |
| Domain | FA58C_1 | 4.16e-03 | 21 | 86 | 2 | PS01285 | |
| Domain | FA58C_2 | 4.16e-03 | 21 | 86 | 2 | PS01286 | |
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 21335558 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | KLHL6 DDR1 DFFB ATRX DDR2 FER SNX27 DDX60L EIF3C PLEC MAPK3 PICALM EIF3CL | 5.56e-07 | 910 | 89 | 13 | 36736316 |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 2.97e-06 | 344 | 89 | 8 | 30333137 | |
| Pubmed | IPO5 GPHN ACSL6 DMXL2 KIDINS220 UBAP2L PI4KA PABPC4 ETF1 SNX27 EIF3C PLEC MAPK3 PABPC1 EIF3CL | 3.32e-06 | 1431 | 89 | 15 | 37142655 | |
| Pubmed | 5.34e-06 | 497 | 89 | 9 | 23414517 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 27008860 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 7774938 | ||
| Pubmed | PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling. | 6.48e-06 | 2 | 89 | 2 | 21140374 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 24018687 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 12628722 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 30458172 | ||
| Pubmed | Control of bone mass and remodeling by PTH receptor signaling in osteocytes. | 6.48e-06 | 2 | 89 | 2 | 18698360 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 28863860 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 17113033 | ||
| Pubmed | Direct binding of plectin to Fer kinase and negative regulation of its catalytic activity. | 6.48e-06 | 2 | 89 | 2 | 12200133 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 32047176 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 26702058 | ||
| Pubmed | EIF3C Promotes Lung Cancer Tumorigenesis by Regulating the APP/HSPA1A/LMNB1 Axis. | 6.48e-06 | 2 | 89 | 2 | 36157221 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 15111304 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 29616590 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 25667101 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 8197172 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 23307244 | ||
| Pubmed | Netrin-1-mediated axon outgrowth requires deleted in colorectal cancer-dependent MAPK activation. | 6.48e-06 | 2 | 89 | 2 | 11986622 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 19900459 | ||
| Pubmed | Discoidin domain receptors: a promoter of the aggressive behavior of ameloblastomas. | 6.48e-06 | 2 | 89 | 2 | 24723326 | |
| Pubmed | Identification of a gephyrin binding motif on the glycine receptor beta subunit. | 6.48e-06 | 2 | 89 | 2 | 7546736 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 24361528 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 38725848 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 25470979 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 26912788 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 12935821 | ||
| Pubmed | Discoidin domain receptor (DDR) 1 and 2: collagen-activated tyrosine kinase receptors in the cornea. | 6.48e-06 | 2 | 89 | 2 | 11133186 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 23822953 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 17299390 | ||
| Pubmed | Complex roles of discoidin domain receptor tyrosine kinases in cancer. | 6.48e-06 | 2 | 89 | 2 | 33634432 | |
| Pubmed | Histone H3.3 maintains genome integrity during mammalian development. | 8.86e-06 | 16 | 89 | 3 | 26159997 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | IPO5 PTPN11 KIDINS220 LMAN1 ATRX UBAP2L PI4KA PABPC4 ETF1 EIF3C DNAH5 PABPC1 EIF3CL MYBPC1 | 1.52e-05 | 1425 | 89 | 14 | 30948266 |
| Pubmed | 1.74e-05 | 124 | 89 | 5 | 35516420 | ||
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 1.77e-05 | 211 | 89 | 6 | 24097068 | |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 26613940 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 17658952 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 17145751 | ||
| Pubmed | Pinpointing phosphotyrosine-dependent interactions downstream of the collagen receptor DDR1. | 1.94e-05 | 3 | 89 | 2 | 16337946 | |
| Pubmed | The discoidin domain receptor DDR2 is a receptor for type X collagen. | 1.94e-05 | 3 | 89 | 2 | 16806867 | |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 33239676 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 31077665 | ||
| Pubmed | Regulation of glycine receptor diffusion properties and gephyrin interactions by protein kinase C. | 1.94e-05 | 3 | 89 | 2 | 21829170 | |
| Pubmed | Kidins220 deficiency causes ventriculomegaly via SNX27-retromer-dependent AQP4 degradation. | 1.94e-05 | 3 | 89 | 2 | 34002021 | |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 23806693 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 21940797 | ||
| Pubmed | Molecular basis of the alternative recruitment of GABA(A) versus glycine receptors through gephyrin. | 1.94e-05 | 3 | 89 | 2 | 25531214 | |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 17347650 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 11168555 | ||
| Pubmed | Splice-specific roles of glycine receptor alpha3 in the hippocampus. | 1.94e-05 | 3 | 89 | 2 | 19723286 | |
| Pubmed | EB1-binding-myomegalin protein complex promotes centrosomal microtubules functions. | 2.13e-05 | 63 | 89 | 4 | 29162697 | |
| Pubmed | 2.39e-05 | 332 | 89 | 7 | 37433992 | ||
| Pubmed | 2.76e-05 | 23 | 89 | 3 | 30470893 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 3.06e-05 | 475 | 89 | 8 | 31040226 | |
| Pubmed | RGPD4 GPHN SIN3B DMXL2 UBAP2L PI4KA RGPD3 ETF1 MAPK3 PABPC1 PICALM | 3.53e-05 | 963 | 89 | 11 | 28671696 | |
| Pubmed | Biological, clinical and population relevance of 95 loci for blood lipids. | 3.80e-05 | 146 | 89 | 5 | 20686565 | |
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 22371576 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 26047699 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 16492667 | ||
| Pubmed | Shp2E76K mutant confers cytokine-independent survival of TF-1 myeloid cells by up-regulating Bcl-XL. | 3.87e-05 | 4 | 89 | 2 | 17942397 | |
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 10504338 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 30902975 | ||
| Pubmed | Alpha subunit-dependent glycine receptor clustering and regulation of synaptic receptor numbers. | 3.87e-05 | 4 | 89 | 2 | 28883437 | |
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 15356145 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 18316486 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 29503347 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 20432435 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 31813956 | ||
| Pubmed | Excitatory neuron-specific SHP2-ERK signaling network regulates synaptic plasticity and memory. | 3.87e-05 | 4 | 89 | 2 | 30837304 | |
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 16813525 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 23408424 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 15273746 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 36979407 | ||
| Pubmed | 4.53e-05 | 27 | 89 | 3 | 26442671 | ||
| Pubmed | 4.65e-05 | 504 | 89 | 8 | 34432599 | ||
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | 5.17e-05 | 375 | 89 | 7 | 32788342 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 5.23e-05 | 256 | 89 | 6 | 33397691 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 5.28e-05 | 665 | 89 | 9 | 30457570 | |
| Pubmed | Differential expression of C-protein isoforms in developing and degenerating mouse striated muscles. | 6.44e-05 | 5 | 89 | 2 | 10024132 | |
| Pubmed | Netrin1-DCC-Mediated Attraction Guides Post-Crossing Commissural Axons in the Hindbrain. | 6.44e-05 | 5 | 89 | 2 | 26290247 | |
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 9440711 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 20671117 | ||
| Pubmed | HIV- 1 protease inhibits Cap- and poly(A)-dependent translation upon eIF4GI and PABP cleavage. | 6.44e-05 | 5 | 89 | 2 | 19956697 | |
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 18447585 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 20301437 | ||
| Pubmed | EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2. | 6.44e-05 | 5 | 89 | 2 | 12974390 | |
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 16332685 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 33744966 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 18577518 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 20004665 | ||
| Pubmed | IPO5 PTPN11 KIDINS220 UBAP2L PI4KA PABPC4 PLEC PABPC1 PICALM | 8.42e-05 | 707 | 89 | 9 | 19738201 | |
| Pubmed | IPO5 PTPN11 KIDINS220 LMAN1 UBAP2L PABPC4 ETF1 PABPC1 JMJD1C | 8.51e-05 | 708 | 89 | 9 | 39231216 | |
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 9.43e-05 | 92 | 89 | 4 | 15840729 | |
| Pubmed | 9.65e-05 | 6 | 89 | 2 | 27861634 | ||
| Pubmed | The discoidin domain receptor tyrosine kinases are activated by collagen. | 9.65e-05 | 6 | 89 | 2 | 9659899 | |
| Interaction | MEX3A interactions | KLHL6 IPO5 UBAP2L PABPC4 PLEC RBM47 DNAH5 PABPC1 ST14 SLC25A37 | 6.76e-06 | 384 | 88 | 10 | int:MEX3A |
| Cytoband | 11q14 | 2.42e-04 | 12 | 89 | 2 | 11q14 | |
| Cytoband | 16p11.2 | 5.38e-04 | 191 | 89 | 4 | 16p11.2 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 2.23e-06 | 8 | 63 | 3 | 658 | |
| GeneFamily | Fibronectin type III domain containing | 2.37e-04 | 160 | 63 | 5 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.44e-04 | 161 | 63 | 5 | 593 | |
| GeneFamily | Kelch like|BTB domain containing | 4.20e-04 | 42 | 63 | 3 | 617 | |
| GeneFamily | Dyneins, axonemal | 1.57e-03 | 17 | 63 | 2 | 536 | |
| GeneFamily | Acyl-CoA synthetase family | 3.68e-03 | 26 | 63 | 2 | 40 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 7.55e-03 | 115 | 63 | 3 | 769 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 8.56e-03 | 40 | 63 | 2 | 321 | |
| Coexpression | GSE37319_WT_VS_RC3H1_KO_CD44LOW_CD8_TCELL_UP | 1.13e-05 | 149 | 88 | 6 | M8918 | |
| Coexpression | GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_10DY_DN | 2.95e-05 | 106 | 88 | 5 | M41161 | |
| Coexpression | TRAVAGLINI_LUNG_CLASSICAL_MONOCYTE_CELL | 3.55e-05 | 270 | 88 | 7 | M41699 | |
| Coexpression | GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN | 5.74e-05 | 199 | 88 | 6 | M6264 | |
| Coexpression | BASAKI_YBX1_TARGETS_DN | 5.87e-05 | 398 | 88 | 8 | M14877 | |
| Coexpression | GSE11961_MEMORY_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_DN | 5.90e-05 | 200 | 88 | 6 | M9357 | |
| Coexpression | HASLINGER_B_CLL_WITH_11Q23_DELETION | 6.17e-05 | 23 | 88 | 3 | M11509 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | DDR1 DMXL2 PTPN11 KIDINS220 LMAN1 ATRX ATRNL1 PI4KA KLHL42 CHD9 ROBO2 DNAH5 | 7.51e-05 | 946 | 88 | 12 | M39169 |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-06 | 183 | 89 | 6 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | Immune-alveolar_macrophage_(MARCO_positive)|World / Lineage, Cell type, age group and donor | 2.64e-06 | 195 | 89 | 6 | f92114ef995e690a3bedc62c89c5fd6773d0d9f7 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 2.81e-06 | 197 | 89 | 6 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.06e-06 | 200 | 89 | 6 | 2f5b71e55c2de0e77fdae6667eb57f333acc6cd1 | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.05e-05 | 144 | 89 | 5 | f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-dnT|Bac-SEP / Disease, Lineage and Cell Type | 1.74e-05 | 160 | 89 | 5 | f5ca49801c981b903a85a64b21ece6b59fe91cbc | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 2.33e-05 | 170 | 89 | 5 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Uncommitted_AE_cell|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.33e-05 | 170 | 89 | 5 | 5a64e05c263df915085988d881808221e2c0f2e2 | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 3.15e-05 | 181 | 89 | 5 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.32e-05 | 183 | 89 | 5 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.49e-05 | 185 | 89 | 5 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.49e-05 | 185 | 89 | 5 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-05 | 187 | 89 | 5 | 236e9857729670e87eed30fad58f49e1f56e4a85 | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 3.87e-05 | 189 | 89 | 5 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.87e-05 | 189 | 89 | 5 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 3.97e-05 | 190 | 89 | 5 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | Control-Myeloid|Control / group, cell type (main and fine annotations) | 4.07e-05 | 191 | 89 | 5 | 9c4acc5f3c2f9c0c5520863bb22f391774372347 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.07e-05 | 191 | 89 | 5 | 0b296404ebad0aadb75737f8c0462ec6934fc8bb | |
| ToppCell | facs-Skin|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.07e-05 | 191 | 89 | 5 | ae524103331fa53fa82888dbb567fc36abcee7e0 | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|lung / Disease (COVID-19 only), tissue and cell type | 4.07e-05 | 191 | 89 | 5 | dab953682b8c9ed680a799161f837f792a7e4f33 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.07e-05 | 191 | 89 | 5 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.17e-05 | 192 | 89 | 5 | bcfb9c005166bc0b4f8ee2dfc0c1540e8bf0e1ff | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175|Adult / Lineage, Cell type, age group and donor | 4.17e-05 | 192 | 89 | 5 | 733491e932350e3c216a626cc49c3cd3fe970a82 | |
| ToppCell | COVID-19-kidney-Myeloid|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.17e-05 | 192 | 89 | 5 | 0b9d22a222f1201e375f8e55cace9ef939febae4 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.27e-05 | 193 | 89 | 5 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.27e-05 | 193 | 89 | 5 | 5703a6faaee82cbad5ce73429bdf1b0f47b37ee0 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM3-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.27e-05 | 193 | 89 | 5 | 93ba635ed69fec9286fe7636b9d258f3d93a22c3 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.27e-05 | 193 | 89 | 5 | 6dfdeb793cb5ad6412b6f808b5687a4e74b6ec65 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM3-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.38e-05 | 194 | 89 | 5 | e455cb469157c044126f9b0b308957d4ee1e608b | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM3|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.38e-05 | 194 | 89 | 5 | e0cfd18a7ea2251163d61312b9397f8a518c8c51 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.49e-05 | 195 | 89 | 5 | 9d649ac7d2af313481069c95349efc0c68449e2b | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 4.49e-05 | 195 | 89 | 5 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | Mild_COVID-19-Myeloid-MoAM3|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 4.60e-05 | 196 | 89 | 5 | 9faad17aa0b6af5a8ec2dadf7d70b9209d658072 | |
| ToppCell | COVID-19-lung-Macrophage_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 4.60e-05 | 196 | 89 | 5 | a753d76d764c181eecb0e17a794a2e7d0ff70136 | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 4.60e-05 | 196 | 89 | 5 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | BL-critical-LOC-Myeloid|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.71e-05 | 197 | 89 | 5 | 932a7fae4979b561688e6222505df0f4e510ab11 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.71e-05 | 197 | 89 | 5 | e42910a653a1b5bd90c090e9665a84871ed2873f | |
| ToppCell | COVID-19-kidney-Macrophages|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.71e-05 | 197 | 89 | 5 | 3912301018d0863144dcfac8d1fa8adc081748d7 | |
| ToppCell | Children_(3_yrs)-Immune|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.71e-05 | 197 | 89 | 5 | f18807124b91310fcd84238484a80ecdba684679 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.83e-05 | 198 | 89 | 5 | e125eb8aa57c172e5518874da1bd25998292f5e2 | |
| ToppCell | Immune|World / Lineage, Cell type, age group and donor | 4.83e-05 | 198 | 89 | 5 | 65681b54d13c6997bd90a1c2a12314a80e964fe3 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-T/NK-dn_T|Bac-SEP / Disease, condition lineage and cell class | 4.94e-05 | 199 | 89 | 5 | 4150a479b80596accf679b37aa9b0ac15cc132b2 | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.94e-05 | 199 | 89 | 5 | 22001aa733273e784051b7f750e07d99aaf7a225 | |
| ToppCell | Sigmoid-(2)_B_cell-(20)_B_cell_IgA_Plasma|Sigmoid / shred on region, Cell_type, and subtype | 4.94e-05 | 199 | 89 | 5 | f3c583f8521f63834d1afbf8b07940fee7712f9a | |
| ToppCell | Sigmoid-B_cell-B_cell_IgA_Plasma|Sigmoid / Region, Cell class and subclass | 4.94e-05 | 199 | 89 | 5 | 634e0b614ab45e7520da67375b3498db5442b7ae | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.06e-05 | 200 | 89 | 5 | c74bc12e13d002dedaaf75a2244ec111e47524e1 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.06e-05 | 200 | 89 | 5 | a443e475e7a10c26a6173d1af961de6219e0e567 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.06e-05 | 200 | 89 | 5 | ead9eb579bb25fde05fc15602e3d05ab6617f7ac | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.06e-05 | 200 | 89 | 5 | d0167f96314be78b6d867bbcc6e4396071d931b8 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 5.06e-05 | 200 | 89 | 5 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.06e-05 | 200 | 89 | 5 | 8a8f9d9e5ffab3f736c4bd0a5bb616d442d137d1 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.06e-05 | 200 | 89 | 5 | 78d75d381cb2b9a4c9eb7c32a07b014eaee39195 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.06e-05 | 200 | 89 | 5 | 53d5e427f0cbf5cf0b63efe4ec01da302f555704 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.06e-05 | 200 | 89 | 5 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.06e-05 | 200 | 89 | 5 | ed785a6d08ca2b350dc3307b587eadfb2886d1f9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.06e-05 | 200 | 89 | 5 | 74ceebee9af63f8b3ec5857eff1b662752bc3862 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.45e-05 | 103 | 89 | 4 | eb9f008b5fb8a01df8ea4faf6e6aebc1a9db9bd3 | |
| ToppCell | Control-Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.04e-04 | 145 | 89 | 4 | fe68582f5a15b9714cb84fa32ac880e13cb69895 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.27e-04 | 149 | 89 | 4 | c5eedb54ef2e0f131aa6730612c921bc19479632 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.27e-04 | 149 | 89 | 4 | a22417286de8606f0cc94f86b70bce17aeefb9c2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.39e-04 | 151 | 89 | 4 | 7b50425d2bbd7b6ff2a6e67d3e2470a4455740e0 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-04 | 153 | 89 | 4 | 3b1b0cc8e9dd2b1484649789330713282ee44414 | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|Heart / Disease (COVID-19 only), tissue and cell type | 2.63e-04 | 155 | 89 | 4 | d7e26696fd9c0a759524f331243db43059b33ed9 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.83e-04 | 158 | 89 | 4 | 6811dc4f101dfa9a9cc13d949760d43aa522bf3b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.97e-04 | 160 | 89 | 4 | 6ed37d1fd0304932319d6b942502404115ff36a7 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.12e-04 | 162 | 89 | 4 | d712bc31840ad1523e3dbf884acbb428a8995001 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.19e-04 | 163 | 89 | 4 | bba830a302919c8b33f914a8839877fc21dd28a0 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.19e-04 | 163 | 89 | 4 | 8d17f44faf0549fe71a9a45f811f50d767275414 | |
| ToppCell | PSB-critical-LOC-Lymphoid-PC|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.26e-04 | 164 | 89 | 4 | 3e672124dea2497c5bdf8a315c8cfacfab5780dc | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.42e-04 | 166 | 89 | 4 | f62db9d9b6c9dd8f2afcaea0fc5f8c69f50205b2 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.50e-04 | 167 | 89 | 4 | 91b14df450bfb6a2b406c88f8c75cd51eeb9e82b | |
| ToppCell | facs-Kidney|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-04 | 168 | 89 | 4 | d2f17a470e04f8f0edb111894027bcfc6ee1a12f | |
| ToppCell | Control-Hematopoietic_Meg-Ery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.66e-04 | 169 | 89 | 4 | c2e2a7b89fe4a64d79efafdec037c4104f433061 | |
| ToppCell | Control-Hematopoietic_Meg-Ery-Erythroid|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.66e-04 | 169 | 89 | 4 | df1fc1477bbbb285063b9b122b1ac84c87fd7fa8 | |
| ToppCell | Control-Hematopoietic_Meg-Ery-Erythroid-Erythroid|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.66e-04 | 169 | 89 | 4 | 92986559aa4a744e8b0487b0ae035cfb1fbf9890 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-04 | 171 | 89 | 4 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-04 | 171 | 89 | 4 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.91e-04 | 172 | 89 | 4 | 415d57aa6278b8c12e7a2cf9c3fa5283389fb9b0 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-04 | 172 | 89 | 4 | 4790323a072cfe76127d704665a42c09601d84be | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.91e-04 | 172 | 89 | 4 | 381ae1c3c07d0a424f43455ec571653b192a946a | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.00e-04 | 173 | 89 | 4 | 46ed379571385684145b5cb6dd4ae340ac546e64 | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-04 | 173 | 89 | 4 | f0eb48c1283bdde313bb75f6ffc0d2626922d24b | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.17e-04 | 175 | 89 | 4 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.17e-04 | 175 | 89 | 4 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-04 | 175 | 89 | 4 | f24b664b9056b5976bf2222e8013f15c09e049ad | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.17e-04 | 175 | 89 | 4 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-04 | 176 | 89 | 4 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-04 | 176 | 89 | 4 | 8e4600efeea095a92178cfd26d7c58db7dfc0c80 | |
| ToppCell | COVID-19-lung-MAST|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.26e-04 | 176 | 89 | 4 | 473c45a381ca109207d66ed1635668b391ea0e1f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.36e-04 | 177 | 89 | 4 | 84116796ca4c7007508c0f1a68a1135c7b922278 | |
| ToppCell | metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 4.36e-04 | 177 | 89 | 4 | 43e1d0d3cf8f0c02e67d91f8dd1761df23d59e07 | |
| ToppCell | droplet-Heart-4Chambers-21m-Hematologic-erythrocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-04 | 74 | 89 | 3 | 6f222ebf7cb106bbb2ae3fb3cda660dfec3ea5d0 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.45e-04 | 178 | 89 | 4 | 0b398656f26c4061b11ccf98908d0e2e1367585a | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-04 | 178 | 89 | 4 | 09a215a0d6e98e4bb920cabda12af08ff4de3c98 | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.54e-04 | 179 | 89 | 4 | 7329b45376a9e9a4fe34d4aa0b33af6dda0a8e3b | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery-Erythroid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.54e-04 | 179 | 89 | 4 | 6e4740f99f66d3e9348fa5057cf1030454819aa8 | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.54e-04 | 179 | 89 | 4 | ee60ac43fb62c09967a26bbcf9306ac5ea2bdc1e | |
| ToppCell | IPF-Epithelial-Mesothelial|IPF / Disease state, Lineage and Cell class | 4.64e-04 | 180 | 89 | 4 | 1fa54bf4dba72866b2295639d991af639341bc08 | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 4.64e-04 | 180 | 89 | 4 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.64e-04 | 180 | 89 | 4 | 392bc71a69653ba12de31bed4e9357f181094641 | |
| Computational | Genes in the cancer module 186. | 1.43e-04 | 20 | 56 | 3 | MODULE_186 | |
| Computational | Neighborhood of ZNF10 | 1.60e-04 | 53 | 56 | 4 | MORF_ZNF10 | |
| Disease | Enchondromatosis | 4.90e-05 | 4 | 85 | 2 | C0014084 | |
| Disease | Disproportionate short stature | 7.39e-05 | 77 | 85 | 4 | C0878659 | |
| Disease | cognitive function measurement, self reported educational attainment | 7.59e-05 | 355 | 85 | 7 | EFO_0004784, EFO_0008354 | |
| Disease | Hereditary Hyperexplexia | 8.15e-05 | 5 | 85 | 2 | C1835614 | |
| Disease | Hereditary hyperekplexia | 8.15e-05 | 5 | 85 | 2 | cv:C1835614 | |
| Disease | Hyperekplexia | 1.22e-04 | 6 | 85 | 2 | cv:C0234166 | |
| Disease | N-acylethanolamine-hydrolyzing acid amidase measurement | 2.91e-04 | 9 | 85 | 2 | EFO_0008240 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 3.00e-04 | 45 | 85 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | gastrin-releasing peptide measurement | 4.44e-04 | 11 | 85 | 2 | EFO_0022000 | |
| Disease | Paranoia | 4.44e-04 | 11 | 85 | 2 | C1456784 | |
| Disease | Ischemic stroke, fibrinogen measurement | 5.43e-04 | 55 | 85 | 3 | EFO_0004623, HP_0002140 | |
| Disease | chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology) | 7.30e-04 | 14 | 85 | 2 | DOID:0060413 (implicated_via_orthology) | |
| Disease | C-X-C motif chemokine 11 measurement | 7.30e-04 | 14 | 85 | 2 | EFO_0008057 | |
| Disease | free androgen index | 7.51e-04 | 374 | 85 | 6 | EFO_0007005 | |
| Disease | Situs ambiguus | 8.40e-04 | 15 | 85 | 2 | C0266642 | |
| Disease | gait measurement | 9.44e-04 | 150 | 85 | 4 | EFO_0007680 | |
| Disease | 5-oxoproline measurement | 9.59e-04 | 16 | 85 | 2 | EFO_0010988 | |
| Disease | MYELODYSPLASTIC SYNDROME | 9.67e-04 | 67 | 85 | 3 | C3463824 | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.05e-03 | 69 | 85 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | Van Buchem disease | 1.08e-03 | 17 | 85 | 2 | C0432272 | |
| Disease | serum gamma-glutamyl transferase measurement | 1.27e-03 | 914 | 85 | 9 | EFO_0004532 | |
| Disease | Dyschondroplasias | 1.36e-03 | 19 | 85 | 2 | C0013366 | |
| Disease | acetate measurement | 1.51e-03 | 20 | 85 | 2 | EFO_0010112 | |
| Disease | age of onset of asthma | 1.56e-03 | 79 | 85 | 3 | OBA_2001001 | |
| Disease | bilirubin measurement | 1.76e-03 | 442 | 85 | 6 | EFO_0004570 | |
| Disease | lipid measurement, lipoprotein measurement | 2.26e-03 | 90 | 85 | 3 | EFO_0004529, EFO_0004732 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 2.56e-03 | 197 | 85 | 4 | EFO_0005680 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LDGLNRNYRYVVMDF | 296 | P17516 | |
| YRTEGGYYQITGRMD | 536 | Q9NUB1 | |
| GYYQITGRMDDVINI | 541 | Q9NUB1 | |
| MYFGRQSQADYETRA | 431 | Q9NP61 | |
| VAVYRMTYVGVGANR | 1391 | Q96Q42 | |
| GMSRNLYAGDYYRVQ | 786 | Q08345 | |
| RLRSMQYNGSYFDRG | 196 | O76075 | |
| QYYLTGAQDGSVRMF | 2776 | Q8TDJ6 | |
| IGQFLRTYFRMNYTG | 146 | P52569 | |
| TRMRFNYQGNKFGIV | 2791 | Q9Y485 | |
| YIERFNIALGQYMGA | 206 | Q86Y37 | |
| RTGYSMVQENGQRKY | 41 | A0AV96 | |
| AYRVNGQYIMEGLAS | 76 | Q9NRP0 | |
| IAGQERFGNMTRVYY | 66 | P57729 | |
| NYRDGMGRVLAQDVY | 346 | Q9NQX3 | |
| MITRRSLGYAYVNFQ | 46 | P11940 | |
| NMDTFYRRGISYFGQ | 306 | Q6IE37 | |
| MITRRSLGYAYVNFQ | 46 | Q13310 | |
| TMYYFRIQARNSKGV | 1016 | P43146 | |
| AYREYIAQMSQLEGG | 1386 | Q9ULH0 | |
| DRIYVVGGAMRALYA | 516 | Q8WZ60 | |
| RYMVSGTNVYGILRA | 121 | O43292 | |
| MSRNLYSGDYYRIQG | 731 | Q16832 | |
| IFMQGPYSLNGYRVR | 181 | Q15652 | |
| AERGYLYFTNMQDRA | 1076 | O75197 | |
| LVENMGRVNYGAYIN | 476 | P16278 | |
| VYLDALNYRQMSGRA | 1296 | Q5H9U9 | |
| GDRVIYTNNQRYMAA | 121 | Q9BX97 | |
| QYGEVMVRFSTYFFR | 346 | Q8N119 | |
| TVRYMIGEVQYGGRV | 4106 | Q96JB1 | |
| RNRYAGEVYGMIRFS | 1146 | P42356 | |
| LFIGYIMYRSQQEAA | 491 | P49257 | |
| MYLYGQGIRQDTEAA | 216 | Q9P2M1 | |
| YSGVFRDAYGEFMIQ | 541 | Q96RT7 | |
| TLRRQVGFYMMGVYA | 261 | P48167 | |
| RYTQLQYIGEGAYGM | 41 | P27361 | |
| RSGMVQTEAQYRFIY | 501 | Q06124 | |
| GVLDRGYRYDMSTQE | 186 | A5LHX3 | |
| NFENMDTFYRRGISY | 331 | Q6IE36 | |
| YDMYVGLVNLRVAGN | 111 | A1L453 | |
| VRQAAAYGLGVMAQY | 921 | O00410 | |
| LMNQTYREEYRGFLN | 121 | Q9BZM2 | |
| MGSGLNSFYDQREYI | 586 | A6NKT7 | |
| EGYMRRGGYRQQQSQ | 896 | Q99613 | |
| VGDGYSYRGKMNRTV | 196 | Q14520 | |
| NEGYMRRGGYRQQQS | 896 | B5ME19 | |
| IGYEMYRNLAQGRNV | 1681 | P46100 | |
| YEMYFRDSQGRIIRG | 951 | Q3L8U1 | |
| GGAEQYVLYMVSRNG | 81 | P52797 | |
| YTQRSLLVMGRGYNY | 536 | O94808 | |
| IIQYVDNMYRFEGTG | 506 | P16591 | |
| ALYQENIFMYGGRIE | 361 | Q5VV63 | |
| YRVMFEAGYLTIFGR | 176 | P22680 | |
| TIRYMIGEIQYGGRV | 4241 | Q8TE73 | |
| MGSGLNSFYDQREYI | 586 | Q7Z3J3 | |
| EMIGNYAVRFRLYGV | 336 | Q8NB59 | |
| LQDFVNDVYVYGMRG | 506 | P09917 | |
| TLAIYDRFGRLMYGQ | 221 | Q9BRJ2 | |
| AGYFKGIQARVIYQM | 296 | Q9NYZ2 | |
| FINYYGMQRFGTTAV | 371 | Q96PZ0 | |
| VFIVNSEDYMYRRGT | 1066 | O75182 | |
| GRYRFMGTEAYAESI | 376 | Q07837 | |
| GRQTDFGMYDYFTRQ | 396 | A4QPH2 | |
| YDDARTMYQVFRRGL | 86 | Q9UKU0 | |
| MNRYTTIRQLGDGTY | 1 | Q9UPZ9 | |
| YGFTFLGNRNGYMRV | 511 | Q8NB49 | |
| MVYGNERFIQYLASR | 86 | Q13492 | |
| AQGRFDEAYIYMQRA | 291 | Q6DKK2 | |
| FNVKEGRTRYRMFAY | 431 | Q5GH73 | |
| QVYGYDDLQMLQTRF | 816 | Q14157 | |
| REVFDRLGMIYTVGY | 181 | Q03431 | |
| YRDVRVQKVFNGYMR | 81 | Q9Y5Y6 | |
| VFSNGGVMLYRYVLE | 111 | Q6P2H8 | |
| YMQRVFKYLGEQGVR | 71 | Q8TCT1 | |
| YGSNRFYDNIEDMIG | 491 | P48066 | |
| NGEKFVVYNVYMAGR | 176 | Q96L92 | |
| QGYRVMYRQTSGLQA | 666 | Q9HCK4 | |
| YQRGYFSEEMNRVLA | 3626 | Q15149 | |
| AQRALYRDVMQETYG | 46 | P0C7X2 | |
| AGISYRQFEGLMRFY | 356 | Q9ULQ1 | |
| ELNCQAMGYRFYVRQ | 346 | Q6ZMP0 | |
| ERGSYVRYNFMNDGF | 121 | Q96LC7 | |
| QRGLYRDVMLETYGN | 56 | Q8IZ26 | |
| RGYNSVMNESERFYR | 756 | Q7Z570 | |
| GILRYRVDFQGMEYQ | 411 | P62495 | |
| MEEYLYAVGGRNELR | 396 | Q96NJ5 | |
| IYVIGGYTTRDRNMN | 346 | Q9P2K6 | |
| MAGQSREDYIYGFQF | 121 | Q13508 | |
| YVFRVRAMNQYGLSD | 571 | Q5VTT5 | |
| VIGNEYYFRVFSENM | 996 | Q00872 | |
| IGNGYYFRVFSQNMV | 1131 | Q14896 |